Geoffrey S. Martha

Chairman and Chief Executive Officer at Medtronic

Board

Since April 27, 2020

Age

54 years

Tenure

Joined MDT’s Board of Directors in November 2019, served as President until April 2020 before being appointed CEO on April 27, 2020 and later as Chairman on December 11, 2020.

Also at Medtronic

Gary Corona

Interim Chief Financial Officer

IKF

Ivan K. Fong

EVP, General Counsel, and Corporate Secretary

Michael Marinaro

EVP and President, Medical Surgical Portfolio

About

Currently, the Chairman and Chief Executive Officer of Medtronic plc, the world’s largest medical technology company, assumed responsibility as CEO on 04-27-2020 following a key period as President after joining the board in 11-2019.

Over an extensive career, significant leadership roles at Medtronic were complemented by earlier positions at GE Healthcare and GE Capital, where valuable strategic expertise was developed. This progression of roles underscores a deep commitment to advancing healthcare innovation and corporate transformation.

Beyond the boardroom, a passion for hockey has been a defining personal characteristic, highlighted by a past as the captain of the Penn State Men’s hockey team and subsequent induction into its Hockey Hall of Fame, reflecting leadership and dedication both on and off the field.

$MDT Performance Under Geoffrey S. Martha

Past Roles

Organization	Role	Date Range	Details
Medtronic	President of Medtronic	November 2019 - April 2020	Held prior to his appointment as Chairman and CEO
Medtronic	Executive Vice President and President, Restorative Therapies Group	Since August 2015 until transition to CEO	Position held before becoming Chairman and CEO
Medtronic	Senior Vice President of Strategy and Business Development	Medtronic, Inc.: Since August 2011; Medtronic plc: Since January 2015	Combined role details for both Medtronic entities
General Electric (GE) Healthcare	Managing Director of Business Development	April 2007 - July 2011	Role held at GE Healthcare
General Electric (GE) Capital	General Manager, Technology Finance Services	November 2003 - March 2007	Role held at GE Capital
General Electric (GE) Capital	Senior Vice President, Business Development for Vendor Financial Services	February 2002 - October 2003	Role held at GE Capital
General Electric (GE) Capital	General Manager, Colonial Pacific Leasing	February 2001 - January 2002	Role held at GE Capital
General Electric (GE) Capital	Vice President, Business Development for Potomac Federal	May 1998 - January 2001	Potomac Federal is the GE Capital federal financing investment bank

External Roles

Organization	Role	Date Range	Details
Business Roundtable	Active Member	N/A	N/A
World Economic Forum’s International Business Council	Active Member	N/A	N/A
U.S.-China Business Council	Board of Directors	N/A	N/A
AdvaMed	Treasurer	N/A	N/A
Asia Society	Board of Trustees	N/A	N/A
Minnesota Business Partnership	President, Executive Committee of the Board of Directors	N/A	N/A

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$1,350,000	Annual	Fixed annual salary; no merit increase in 2024
All Other Compensation	$305,496	Annual	Includes Perquisites and Other Personal Benefits: $223,146 (business allowance $40,000; personal use of company aircraft $182,870; employee program $276) and Company Contributions: $82,350 (qualified PIA $16,500; nonqualified PIA $51,000; MCC $14,850)

Performance Compensation

Data from FY 2024

Medtronic Incentive Plan (MIP)

Metric	Value	Details
Threshold	$1,012,500	Minimum performance level
Target	$2,025,000	Target performance level
Maximum	$4,050,000	Cap on performance payout
MIP Payout	$1,905,272	Achieved payout at 94% multiplier
Target % of Base	150%	Based on base salary
Evaluation Period	FY24	Performance evaluated over fiscal year 2024

Performance Share Units (PSU)

Metric	Value	Details
Threshold Shares	42,731	Minimum shares required
Target Shares	85,461	Target number of shares
Maximum Shares	170,922	Maximum possible shares
Grant Date	July 31, 2023	Grant date
Grant Date Fair Value	$9,023,827	Fair value at grant date
Vesting Schedule	3-year cliff	Vests in 2026 contingent on continued service
Performance Metrics	rTSR, Revenue Growth, ROIC	Metrics used to determine final award
Award Range	0% to 200%	Final award range based on performance

Stock Options (OPT)

Metric	Value	Details
Number of Options	240,691	Total options granted
Grant Date	July 31, 2023	Grant date
Grant Date Fair Value	$4,499,959	Fair value at grant date
Exercise Price	$87.76 per share	Price at grant date
Vesting Schedule	25% annually over 4 years	Time-based vesting schedule

Restricted Stock Units (RSU)

Metric	Value	Details
Number of RSUs	34,185	RSUs granted
Grant Date	July 31, 2023	Grant date
Grant Date Fair Value	$3,000,076	Fair value at grant date
Grant Date Stock Price	$87.76	Stock price at grant date
Vesting Schedule	3-year cliff	Vests on July 31, 2026, subject to continued service
Notes	Not performance-based	Time-based award with dividend equivalent units